Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL METABOLISM
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-10
DOI
10.1007/s00774-021-01206-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways
- (2020) Chang-hong Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline
- (2019) Richard Eastell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- CTLA4‐Ig directly inhibits osteoclastogenesis by interfering with intracellular calcium oscillations in bone marrow macrophages
- (2019) Hiroyuki Okada et al. JOURNAL OF BONE AND MINERAL RESEARCH
- T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB
- (2018) Jinglue Song et al. Biomed Research International
- Analysis of Ca2+ response of osteocyte network by three-dimensional time-lapse imaging in living bone
- (2017) Tomoyo Tanaka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Parathyroid hormone regulates fates of murine osteoblast precursors in vivo
- (2017) Deepak H. Balani et al. JOURNAL OF CLINICAL INVESTIGATION
- Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-γ
- (2017) Ying-Xing Wu et al. Molecular Medicine Reports
- Parathyroid Hormone (PTH) Induces Autophagy to Protect Osteocyte Cell Survival from Dexamethasone Damage
- (2017) Liang Zhu et al. MEDICAL SCIENCE MONITOR
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
- (2017) Lenore Buckley et al. Arthritis & Rheumatology
- Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-κB and MAPK pathways
- (2016) Ke Gan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Advanced oxidation protein products induce apoptosis, and upregulate sclerostin and RANKL expression, in osteocytic MLO-Y4 cells via JNK/p38 MAPK activation
- (2016) Chaoqun Yu et al. Molecular Medicine Reports
- Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation
- (2016) T. Noguchi et al. OSTEOPOROSIS INTERNATIONAL
- Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients
- (2015) Yu Wei et al. Biomed Research International
- A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children
- (2014) Karen E. Hansen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro
- (2013) Shoichi Kaneshiro et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
- T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis
- (2008) Fang Du et al. ARTHRITIS RESEARCH & THERAPY
- Establishment of an Osteocyte-like Cell Line, MLO-Y4
- (2006) Yoichi Kato et al. JOURNAL OF BONE AND MINERAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now